CoChat

Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries

Open access
Mohan, Deepa, Mente, Andrew, Dehghan, Mahshid, Rangarajan, Sumathy, O’Donnell, Martin, Hu, Weihong, Dagenais, Gilles, Wielgosz, Andreas, Lear, Scott, Wei, Li, Diaz, Rafael, Avezum, Alvaro, Lopez-Jaramillo, Patricio, Lanas, Fernando, Swaminathan, Sumathi, Kaur, Manmeet, Vijayakumar, K., Mohan, Viswanathan, Gupta, Rajeev, Szuba, Andrzej, Iqbal, Romaina, Yusuf, Rita, Mohammadifard, Noushin, Khatib, Rasha, Yusoff, Khalid, Gulec, Sadi, Rosengren, Annika, Yusufali, Afzalhussein, Wentzel-Viljoen, Edelweiss, Chifamba, Jephat, Dans, Antonio, Alhabib, Khalid F., Yeates, Karen, Teo, Koon, Gerstein, Hertzel C., Yusuf, Salim, PURE, ONTARGET, TRANSCEND, and ORIGIN investigators · 2021 · JAMA Internal Medicine
Cited by 147

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Importance: Cohort studies report inconsistent associations between fish consumption, a major source of long-chain ω-3 fatty acids, and risk of cardiovascular disease (CVD) and mortality. Whether the associations vary between those with and those without vascular disease is unknown. Objective: To examine whether the associations of fish consumption with risk of CVD or of mortality differ between individuals with and individuals without vascular disease. Design, Setting, and Participants: This pooled analysis of individual participant data involved 191 558 individuals from 4 cohort studies-147 645 individuals (139 827 without CVD and 7818 with CVD) from 21 countries in the Prospective Urban Rural Epidemiology (PURE) study and 43 413 patients with vascular disease in 3 prospective studies from 40 countries. Adjusted hazard ratios (HRs) were calculated by multilevel Cox regression separately within each study and then pooled using random-effects meta-analysis. This analysis was conducted from January to June 2020. Exposures: Fish consumption was recorded using validated food frequency questionnaires. In 1 of the cohorts with vascular disease, a separate qualitative food frequency questionnaire was used to assess intake of individual types of fish. Main Outcomes and Measures: Mortality and major CVD events (including myocardial infarction, stroke, congestive heart failure, or sudden death). Results: Overall, 191 558 participants with a mean (SD) age of 54.1 (8.0) years (91 666 [47.9%] male) were included in the present analysis. During 9.1 years of follow-up in PURE, compared with little or no fish intake (≤50 g/mo), an intake of 350 g/wk or more was not associated with risk of major CVD (HR, 0.95; 95% CI, 0.86-1.04) or total mortality (HR, 0.96; 0.88-1.05). By contrast, in the 3 cohorts of patients with vascular disease, the HR for risk of major CVD (HR, 0.84; 95% CI, 0.73-0.96) and total mortality (HR, 0.82; 95% CI, 0.74-0.91) was lowest with intakes of at least 175 g/wk (or approximately 2 servings/wk) compared with 50 g/mo or lower, with no further apparent decrease in HR with consumption of 350 g/wk or higher. Fish with higher amounts of ω-3 fatty acids were strongly associated with a lower risk of CVD (HR, 0.94; 95% CI, 0.92-0.97 per 5-g increment of intake), whereas other fish were neutral (collected in 1 cohort of patients with vascular disease). The association between fish intake and each outcome varied by CVD status, with a lower risk found among patients with vascular disease but not in general populations (for major CVD, I2 = 82.6 [P = .02]; for death, I2 = 90.8 [P = .001]). Conclusions and Relevance: Findings of this pooled analysis of 4 cohort studies indicated that a minimal fish intake of 175 g (approximately 2 servings) weekly is associated with lower risk of major CVD and mortality among patients with prior CVD but not in general populations. The consumption of fish (especially oily fish) should be evaluated in randomized trials of clinical outcomes among people with vascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2021.0036

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 147

Metadata

Authors
Mohan, D., Mente, A., Dehghan, M., Rangarajan, S., O’Donnell, M., Hu, W., Dagenais, G., Wielgosz, A., Lear, S., Wei, L., Diaz, R., Avezum, A., Lopez-Jaramillo, P., Lanas, F., Swaminathan, S., Kaur, M., Vijayakumar, K., Mohan, V., Gupta, R., Szuba, A., Iqbal, R., Yusuf, R., Mohammadifard, N., Khatib, R., Yusoff, K., Gulec, S., Rosengren, A., Yusufali, A., Wentzel-Viljoen, E., Chifamba, J., Dans, A., Alhabib, K. F., Yeates, K., Teo, K., Gerstein, H. C., Yusuf, S., & PURE, O.
Venue
JAMA Internal Medicine
Published
2021-05-01
Volume
181
Issue
5
Pages
631
ISSN
2168-6106 (ISSN-L)
OpenAlex
W3133676810
Cited by
147
References
30
FWCI
13.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries. https://app.cochat.ai/papers/10.1001/jamainternmed.2021.0036
The paper
Mohan, D., Mente, A., Dehghan, M., Rangarajan, S., O’Donnell, M., Hu, W., Dagenais, G., Wielgosz, A., Lear, S., Wei, L., Diaz, R., Avezum, A., Lopez-Jaramillo, P., Lanas, F., Swaminathan, S., Kaur, M., Vijayakumar, K., Mohan, V., Gupta, R., . . . PURE, O. (2021). Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2021.0036

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.